Flavonoids, gut microbiota and cardiovascular disease: Dynamics and interplay

<p>Cardiovascular disease (CVD) remains the leading cause of global morbidity and mortality. Extensive efforts have been invested to explicate mechanisms implicated in the onset and progression of CVD. Besides the usual suspects as risk factors (obesity, diabetes, and others), the gut microbio...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Hadi Mansour (17821430) (author)
مؤلفون آخرون: Hasan Slika (17821427) (author), Suzanne A. Nasser (17563161) (author), Gianfranco Pintus (91638) (author), Maha Khachab (21633485) (author), Amirhossein Sahebkar (1452028) (author), Ali H. Eid (5461829) (author)
منشور في: 2024
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513545486467072
author Hadi Mansour (17821430)
author2 Hasan Slika (17821427)
Suzanne A. Nasser (17563161)
Gianfranco Pintus (91638)
Maha Khachab (21633485)
Amirhossein Sahebkar (1452028)
Ali H. Eid (5461829)
author2_role author
author
author
author
author
author
author_facet Hadi Mansour (17821430)
Hasan Slika (17821427)
Suzanne A. Nasser (17563161)
Gianfranco Pintus (91638)
Maha Khachab (21633485)
Amirhossein Sahebkar (1452028)
Ali H. Eid (5461829)
author_role author
dc.creator.none.fl_str_mv Hadi Mansour (17821430)
Hasan Slika (17821427)
Suzanne A. Nasser (17563161)
Gianfranco Pintus (91638)
Maha Khachab (21633485)
Amirhossein Sahebkar (1452028)
Ali H. Eid (5461829)
dc.date.none.fl_str_mv 2024-10-08T09:00:00Z
dc.identifier.none.fl_str_mv 10.1016/j.phrs.2024.107452
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Flavonoids_gut_microbiota_and_cardiovascular_disease_Dynamics_and_interplay/29446016
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Cardiovascular medicine and haematology
Immunology
Nutrition and dietetics
Cardiovascular disease
Gut microbiota
Natural polyphenols
Flavonoids
Trimethylamine-N-oxide
Inflammation
Farnesoid X receptor
bile acid
dc.title.none.fl_str_mv Flavonoids, gut microbiota and cardiovascular disease: Dynamics and interplay
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p>Cardiovascular disease (CVD) remains the leading cause of global morbidity and mortality. Extensive efforts have been invested to explicate mechanisms implicated in the onset and progression of CVD. Besides the usual suspects as risk factors (obesity, diabetes, and others), the gut microbiome has emerged as a prominent and essential factor in the pathogenesis of CVD. With its endocrine-like effects, the microbiome modulates many physiologic processes. As such, it is not surprising that dysbiosis-by generating metabolites, inciting inflammation, and altering secondary bile acid signaling- could predispose to or aggravate CVD. Nevertheless, various natural and synthetic compounds have been shown to modulate the microbiome. Prime among these molecules are flavonoids, which are natural polyphenols mainly present in fruits and vegetables. Accumulating evidence supports the potential of flavonoids in attenuating the development of CVD. The ascribed mechanisms of these compounds appear to involve mitigation of inflammation, alteration of the microbiome composition, enhancement of barrier integrity, induction of reverse cholesterol transport, and activation of farnesoid X receptor signaling. In this review, we critically appraise the methods by which the gut microbiome, despite being essential to the human body, predisposes to CVD. Moreover, we dissect the mechanisms and pathways underlying the cardioprotective effects of flavonoids.</p><h2>Other Information</h2> <p> Published in: Pharmacological Research<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.phrs.2024.107452" target="_blank">https://dx.doi.org/10.1016/j.phrs.2024.107452</a></p>
eu_rights_str_mv openAccess
id Manara2_4c67e9dd6b7cbd8c030c078fdc564cd5
identifier_str_mv 10.1016/j.phrs.2024.107452
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/29446016
publishDate 2024
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Flavonoids, gut microbiota and cardiovascular disease: Dynamics and interplayHadi Mansour (17821430)Hasan Slika (17821427)Suzanne A. Nasser (17563161)Gianfranco Pintus (91638)Maha Khachab (21633485)Amirhossein Sahebkar (1452028)Ali H. Eid (5461829)Biomedical and clinical sciencesCardiovascular medicine and haematologyImmunologyNutrition and dieteticsCardiovascular diseaseGut microbiotaNatural polyphenolsFlavonoidsTrimethylamine-N-oxideInflammationFarnesoid X receptorbile acid<p>Cardiovascular disease (CVD) remains the leading cause of global morbidity and mortality. Extensive efforts have been invested to explicate mechanisms implicated in the onset and progression of CVD. Besides the usual suspects as risk factors (obesity, diabetes, and others), the gut microbiome has emerged as a prominent and essential factor in the pathogenesis of CVD. With its endocrine-like effects, the microbiome modulates many physiologic processes. As such, it is not surprising that dysbiosis-by generating metabolites, inciting inflammation, and altering secondary bile acid signaling- could predispose to or aggravate CVD. Nevertheless, various natural and synthetic compounds have been shown to modulate the microbiome. Prime among these molecules are flavonoids, which are natural polyphenols mainly present in fruits and vegetables. Accumulating evidence supports the potential of flavonoids in attenuating the development of CVD. The ascribed mechanisms of these compounds appear to involve mitigation of inflammation, alteration of the microbiome composition, enhancement of barrier integrity, induction of reverse cholesterol transport, and activation of farnesoid X receptor signaling. In this review, we critically appraise the methods by which the gut microbiome, despite being essential to the human body, predisposes to CVD. Moreover, we dissect the mechanisms and pathways underlying the cardioprotective effects of flavonoids.</p><h2>Other Information</h2> <p> Published in: Pharmacological Research<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.phrs.2024.107452" target="_blank">https://dx.doi.org/10.1016/j.phrs.2024.107452</a></p>2024-10-08T09:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1016/j.phrs.2024.107452https://figshare.com/articles/journal_contribution/Flavonoids_gut_microbiota_and_cardiovascular_disease_Dynamics_and_interplay/29446016CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/294460162024-10-08T09:00:00Z
spellingShingle Flavonoids, gut microbiota and cardiovascular disease: Dynamics and interplay
Hadi Mansour (17821430)
Biomedical and clinical sciences
Cardiovascular medicine and haematology
Immunology
Nutrition and dietetics
Cardiovascular disease
Gut microbiota
Natural polyphenols
Flavonoids
Trimethylamine-N-oxide
Inflammation
Farnesoid X receptor
bile acid
status_str publishedVersion
title Flavonoids, gut microbiota and cardiovascular disease: Dynamics and interplay
title_full Flavonoids, gut microbiota and cardiovascular disease: Dynamics and interplay
title_fullStr Flavonoids, gut microbiota and cardiovascular disease: Dynamics and interplay
title_full_unstemmed Flavonoids, gut microbiota and cardiovascular disease: Dynamics and interplay
title_short Flavonoids, gut microbiota and cardiovascular disease: Dynamics and interplay
title_sort Flavonoids, gut microbiota and cardiovascular disease: Dynamics and interplay
topic Biomedical and clinical sciences
Cardiovascular medicine and haematology
Immunology
Nutrition and dietetics
Cardiovascular disease
Gut microbiota
Natural polyphenols
Flavonoids
Trimethylamine-N-oxide
Inflammation
Farnesoid X receptor
bile acid